Situation tense as interdict is granted to stop taxi violence in Joburg CBD
We hope to vaccinate 80% of elderly population before end of year - Joe Phaahla
Julius Malema says EFF will end poor performance in Free State municipalities
Was there a Masakhane Clinic in Alex? ANC Joburg mayoral candidate denies this
Ramaphosa promises to fix municipalities during Free State campaign blitz
The psychology of voting in local government elections
How adaptable is your business in these changing times?
Your money can benefit South African small businesses
Investment tips: If you're not prepared for the loss you shouldn't take the risk
A third of CEOs at top JSE-listed companies didn't get a salary increase in 2020
'I wasn't told 6-month payment holiday would add 20 months to my loan term'
New data from Yoco shows small business sector has swung into recovery mode
Boost for Bafana as supporters return to the stadium
Stadiums around South Africa readying for the inevitable return of spectators
Shauwn Mkhize is bringing the PSL into disrepute, says caller
Strange encounter with big canine helps remove man's fear of dogs
SA’s DJ Snow drops Adele’s new song 'Easy On Me' remix
Lalela Mswane crowned Miss South Africa 2021
South Africa removed from UK travel red list: 'Huge congratulations to Team SA'
Airbnb set to train 1,000 young entrepreneurs in South Africa as business owners
Pandora Papers: leak exposes Billy Rautenbach, one of Zimbabwe’s richest men
Re-imagining banking in Africa in a post-Covid world
Mitigating the climate crisis and driving inclusive growth in Africa
WATCH: 'Chicken Licken's new TV spot finally gets it absolutely right'
Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
JSE-listed Aspen Pharmacare has struck a deal with US multinational Johnson & Johnson to commercially manufacture its vaccine candidate.
Johnson & Johnson’s “Ad26.COV2-S” vaccine is undergoing clinical trials.
Aspen Pharmacare will make the vaccines at an existing factory in Port Elizabeth if trials are successful and manufacturing terms are finalised.
The facility is capable of making 300 million vaccine doses per year.
Aspen Pharmacare’s share price was up 11.45% on Monday.
The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare.
Johnson & Johnson’s is a $400 billion company… We’re well-positioned… The tech transfer – we’ve started the process…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson… we like their candidate. You only need one shot… and a fridge… They’ve got 60 000 people in their Phase-3 trial…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson promised universal access…
Stephen Saad, CEO - Aspen Pharmacare
We’ll be ready to put a vaccine into the world by March or April next year…
Stephen Saad, CEO - Aspen Pharmacare
Listen to the interview in the audio below.
This article first appeared on CapeTalk : Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
Copyright : https://www.123rf.com/license.php#standardSource : https://www.123rf.com/photo_53976118_little-happy-girl-get-an-injection-vaccination.html?term=vaccine%2Bsmile&vti=mpp4sbopzossai9spw-1-1
More from MyMoney Online
Get rich by investing globally – a guide for beginners on how to invest overseas
Get a good income from your investments – despite low interest rates
The Money Show’s Bruce Whitfield interviews personal finance advisor Warren Ingram.
Read More
Pay less for car insurance - if you're a good driver and/or you don't drive much
Arabile Gumede interviews Christiaan Steyn, Head of at MiWay Blink.
Read More
How investing a third of everything I earned changed my life, forever
The Money Show’s Bruce Whitfield interviews "supersaver" Julia, as he does once every year in July.
Read More
'Offshore investing is a great idea – but be careful where you put your money'
Momentum releases online will generator - and it's free
The Money Show’s Bruce Whitfield interviews Jeffrey Wiseman, CEO at Momentum Trust.
Read More
More from Covid-19 coronavirus explained
Aspen releases first batch of locally finished J&J Covid-19 vaccines for Africa
The Money Show’s Bruce Whitfield interviews Aspen Pharmacare's Stavros Nicolau.
Read More
'We can’t take an extension of lockdown. We’re out of ideas!'
Ray White interviews Marc Waschsberger, Managing Director at The Capital.
Read More
Current lockdown likely to be extended beyond 14 days - economists
Ray White interviews Hugo Pienaar, Chief Economist at the Bureau for Economic Research (SU).
Read More
'It doesn’t make sense to keep restaurants open at risk to the rest of economy'
The Money Show’s Bruce Whitfield interviews Dr Neva Makgetla, a Senior Economist at TIPS.
Read More
Sun International shuts down all its hotels
The Money Show’s Bruce Whitfield interviews Anthony Leeming, CEO at Sun International Group.
Read More
We need to be closing schools. We need a form of lockdown - Netcare CEO
The Money Show’s Bruce Whitfield interviews Dr Richard Friedland, CEO at Netcare.
Read More
Can your boss force you to be vaccinated against Covid-19? Yes, she can. But…
The Money Show’s Bruce Whitfield interviews Deale Attorneys labour lawyer Patrick Deale.
Read MoreMore from Information about Covid-19 coronavirus
Aspen releases first batch of locally finished J&J Covid-19 vaccines for Africa
The Money Show’s Bruce Whitfield interviews Aspen Pharmacare's Stavros Nicolau.
Read More
'We can’t take an extension of lockdown. We’re out of ideas!'
Ray White interviews Marc Waschsberger, Managing Director at The Capital.
Read More
Current lockdown likely to be extended beyond 14 days - economists
Ray White interviews Hugo Pienaar, Chief Economist at the Bureau for Economic Research (SU).
Read More
'It doesn’t make sense to keep restaurants open at risk to the rest of economy'
The Money Show’s Bruce Whitfield interviews Dr Neva Makgetla, a Senior Economist at TIPS.
Read More
We need to be closing schools. We need a form of lockdown - Netcare CEO
The Money Show’s Bruce Whitfield interviews Dr Richard Friedland, CEO at Netcare.
Read More
Can your boss force you to be vaccinated against Covid-19? Yes, she can. But…
The Money Show’s Bruce Whitfield interviews Deale Attorneys labour lawyer Patrick Deale.
Read More
Aspen Pharmacare has a plan to save South Africa’s vaccine rollout
The Money Show’s Bruce Whitfield interviews Stephen Saad, CEO at Aspen Pharmacare.
Read More
Highlights